Clinical Trial Update: A Clinical Study of Oglemilast in Patients With Mild to Moderate Persistent Asthma [Phase 2]

View source ↗

Summary

Phase 2 clinical study of oglemilast in adults with mild to moderate persistent asthma; the entry provides limited information with no results available.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• Oglemilast (oglemilast)

Snippet

Sponsor: Glenmark Pharmaceuticals Europe Ltd. (R&D) | Conditions: Asthma | Phase 2 | Status: UNKNOWN